- In April 2023, GlaxoSmithKline plc (GSK) launched a targeted oral health awareness campaign in Southeast Asia to address rising cases of glossitis linked to nutritional deficiencies. The initiative included the distribution of educational materials and free vitamin B12 supplements in underserved communities, highlighting GSK’s commitment to preventive healthcare and its focus on mitigating micronutrient-related oral health issues through public health outreach and early intervention strategies
- In March 2023, Pfizer Inc. initiated a clinical study evaluating the efficacy of a new multivitamin formulation specifically designed to treat atrophic glossitis in elderly populations. The study, conducted across multiple geriatric centers in the U.S. and Europe, aims to develop tailored therapeutic options for age-related oral inflammatory conditions. This research effort reinforces Pfizer’s investment in specialized treatments addressing nutritional and autoimmune causes of glossitis
- In March 2023, the Indian Council of Medical Research (ICMR), in collaboration with the Ministry of Health, launched a nationwide program to identify and manage glossitis caused by iron and folate deficiencies among women and children. The program includes community health worker training, mobile diagnostic units, and free supplement distribution, emphasizing the role of early diagnosis in preventing complications. This initiative underscores the growing recognition of glossitis as a public health indicator for nutritional health in developing regions
- In February 2023, Colgate-Palmolive introduced a new medicated oral rinse in Latin America formulated to relieve symptoms of glossitis and improve tongue hygiene. The product, enriched with natural anti-inflammatory agents and mild antiseptics, supports Colgate’s strategy of expanding its therapeutic oral care portfolio while addressing region-specific oral health concerns. The launch reflects increasing consumer demand for OTC solutions tailored to inflammatory oral condition
- In January 2023, Nestlé Health Science announced the development of a new line of medical nutrition products targeting oral mucosal health, including formulations beneficial for glossitis management. These supplements are designed to support individuals with vitamin B complex and iron deficiencies and will be marketed through both clinical channels and retail outlets. This innovation aligns with Nestlé’s mission to offer science-backed nutritional therapies for improving quality of life and managing deficiency-related disorders globally
